Recruiting Friedreich Ataxia Studies in Columbus
About Friedreich Ataxia Clinical Trials in Columbus
Friedreich ataxia is a rare inherited disease that causes progressive damage to the nervous system and movement problems. It is caused by reduced frataxin protein from a GAA repeat expansion. Treatment includes supportive care, with omaveloxolone recently approved.
There are currently 3 friedreich ataxia clinical trials recruiting participants in Columbus, OH. These studies are seeking a combined 3,095 participants. Research is being sponsored by Friedreich's Ataxia Research Alliance, Larimar Therapeutics, Inc., Solid Biosciences Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Friedreich Ataxia Clinical Trials in Columbus — FAQ
Are there friedreich ataxia clinical trials in Columbus?
Yes, there are 3 friedreich ataxia clinical trials currently recruiting in Columbus, OH. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Columbus?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you about next steps.
Are clinical trials in Columbus free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbus studies also compensate for your time and travel.
What friedreich ataxia treatments are being tested?
The 3 active trials in Columbus are testing new therapies including novel drugs, biologics, and treatment approaches for friedreich ataxia.
Data updated October 17, 2026 from ClinicalTrials.gov